111 related articles for article (PubMed ID: 14159819)
1. THE EFFECT OF SOME PHYSIOLOGICAL STIMULI ON FIBRINOLYTIC ACTIVITY IN MAN MEASURED BY THE HEPARIN FRACTIONATION METHOD.
THOMSON WB; GREEN J; EVANS IL
J Clin Pathol; 1964 May; 17(3):341-4. PubMed ID: 14159819
[No Abstract] [Full Text] [Related]
2. THE EFFECT OF INDUCED FIBRINOLYSIS AND VARIOUS SUBSTANCES ON THE MAST CELLS IN THE PERITONEAL FLUID AND MESENTERY OF THE RAT.
CRONBERG S; NILSSON IM
Acta Pathol Microbiol Scand; 1964; 60():156-63. PubMed ID: 14121975
[No Abstract] [Full Text] [Related]
3. UROKINASE AND NON-ENZYMATIC FIBRINOLYTIC AGENTS.
MCNICOL GP; DOUGLAS AS
Scand J Clin Lab Invest; 1964; 16():SUPPL 78:34-6. PubMed ID: 14199707
[No Abstract] [Full Text] [Related]
4. THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN.
NILSSON IM; BIELAWIEC M; BJOERKMAN SE
Scand J Haematol; 1964; 1():75-88. PubMed ID: 14175721
[No Abstract] [Full Text] [Related]
5. [EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
DE WIT CD; MOERS AM; DEN OTTOLANDERGJ
Ned Tijdschr Geneeskd; 1964 Aug; 108():1482-5. PubMed ID: 14182799
[No Abstract] [Full Text] [Related]
6. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
[No Abstract] [Full Text] [Related]
7. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
BIELAWIEC M; NILSSON IM
Scand J Clin Lab Invest; 1964; 16():513-20. PubMed ID: 14209211
[No Abstract] [Full Text] [Related]
8. [FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT].
STOICHITA M
Med Interna (Bucur); 1964 Oct; 16():1163-72. PubMed ID: 14244194
[No Abstract] [Full Text] [Related]
9. The effect of heparin on the fibrinolytic activity of streptokinase-activated human plasma.
KONTTINEN Y
Scand J Clin Lab Invest; 1962; 14():15-8. PubMed ID: 14458290
[No Abstract] [Full Text] [Related]
10. [ON THE ACTION OF THROMBOLYTIC DRUGS].
PATEL J; CORMIER JM
Mem Acad Chir (Paris); 1964 Jun; 90():628-30. PubMed ID: 14179177
[No Abstract] [Full Text] [Related]
11. CURRENT STATUS OF THROMBOLYTIC THERAPY.
SHERRY S
Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
[No Abstract] [Full Text] [Related]
12. HEPARIN FRACTIONATION IN THE STUDY OF LYTIC ACTIVITY.
GREEN J
J Clin Pathol; 1964 May; 17(3):316-8. PubMed ID: 14159470
[No Abstract] [Full Text] [Related]
13. INTERACTION OF HEPARIN WITH FIBRINOLYSIS.
HOLEMANS R; ADAMIS D; HORACE JF
Thromb Diath Haemorrh; 1963 Jul; 143():446-58. PubMed ID: 14081266
[No Abstract] [Full Text] [Related]
14. DRUGS USED IN PERIPHERAL VASCULAR DISEASES.
ABRAMSON DI
Am J Cardiol; 1963 Aug; 12():203-15. PubMed ID: 14054104
[No Abstract] [Full Text] [Related]
15. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
CLIFFTON EE
Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
[No Abstract] [Full Text] [Related]
16. [APROPOS OF THROMBOLYTIC THERAPY].
DONNER L
Cas Lek Cesk; 1964 Jan; 103():102-7. PubMed ID: 14129510
[No Abstract] [Full Text] [Related]
17. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
KOLLER F
Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
[No Abstract] [Full Text] [Related]
18. QUANTITATIVE EVALUATION OF FIBRINOLYTIC ENZYMES IN A SIMULATED HUMAN SYSTEM.
MUNSON AE; BACK N; AMBRUS CM; LASSMAN H; LIPPSCHUTZ E; AMBRUS JL
J Appl Physiol; 1964 May; 19():536-9. PubMed ID: 14174592
[No Abstract] [Full Text] [Related]
19. THROMBOLYTIC THERAPY.
MCNICOL GP; DOUGLAS AS
J Clin Pathol; 1964 May; 17(3):338-40. PubMed ID: 14159477
[No Abstract] [Full Text] [Related]
20. ACTIVATION OF THE FIBRINOLYTIC SYSTEM IN HUMAN BLOOD BY STREPTOKINASE AND CHANGES IN THIS SYSTEM AND IN THE EUGLOBULIN CLOT LYSIS TIME IN RELATION TO AGE AND SEX.
KONTTINEN YP
Scand J Clin Lab Invest; 1965; 17():SUPPL 82:1-111. PubMed ID: 14320094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
